SUMMARY Food and insulin hypoglycaemia raise plasma concentrations of somatostatin. Both also stimulate gastric acid secretion but it is not clear whether gastric acid itself has any effect on somatostatin secretion. We, therefore, studied the effect on plasma concentrations of somatostatin of infusion of 0.1 N HC1 into the stomach and duodenum of healthy subjects. Plasma somatostatin did not rise with a small dose of HC1 given intragastrically (15 mmol) or intraduodenally (4 mmol). After an intraduodenal infusion of 60 mmol HC1 over 30 minutes, sufficient to reduce intraluminal pH to 2, plasma somatostatin rose moderately in five subjects from a mean value (±SEM) of 32±3 pg/ml to a peak at 10 minutes of 54±11 pg/ml. It is concluded that: (a) intragastric acid infusions do not release circulating somatostatin in man; and (b) that intraduodenal acidification albeit at grossly supraphysiological doses is a moderate stimulus of plasma somatostatin release. Therefore, gastric acid is unlikely to be a major factor mediating postprandial plasma somatostatin release in man.
Somatostatin is a tetradecapeptide widely distributed in brain, gut, and pancreas of many species with the greatest abundance in stomach, duodenum and pancreas. 1 2 When administered exogenously in pharmacological doses it has many inhibitory actions, both endrocrine and non-endocrine. 3 We have shown that circulating concentrations of somatostatin rise in man after oral ingestion of a meal4 or individual nutrients, especially fat or protein,5 and after insulin-induced hypoglycaemia.6 Both oral food and hypoglycaemia are stimuli of gastric acid secretion.7 It is possible that gastric acid is one factor stimulating somatostatin release. Somatostatin is a potent inhibitor of gastric acid secretion8 and therefore may participate in a negative feedback loop.
The present study was designed to investigate whether intragastric or intraduodenal acid can release somatostatin into peripheral plasma in normal subjects.
Methods

SUBJECTS
Fourteen male volunteers, mean age 22 years (range 21-24 years) were within 10% of their ideal body weight and taking no medication. None had a history of endocrine, gastrointestinal or renal disease. After an overnight fast the subject was intubated by mouth with a fine bore flexible tube and its tip was positioned in the stomach or second part of duodenum under radiographic control. Two separate studies were conducted.
INTRAGASTRIC INFUSION
Six subjects each received on two separate occasions, an intragastric infusion of (a) 15 mmol 0O 1 N isotonic HC1, and (b) a control intragastric infusion of 150 ml 0-15 N NaCl each given over 30 minutes. Intragastric pH was continuously monitored during the infusions and up to 110 minutes thereafter by a pH-sensitive radiotelemetry capsule tethered 5 cm beyond the distal aperture of the infusion tube. to a nadir of 2-0±0*1 at two minutes and remained low thoughout the infusion. Intraluminal pH rapidly returned to its pre-infusion level when the infusion had been completed. Plasma somatostatin rose from a basal concentration 32±3 pg/ml to a peak of 54±11 pg/ml at 10 minutes (p<0-05 vs basal); and was significantly raised at 20 minutes 46±5 pg/ml (p<0-01) and 30 minutes 45±5 pg/ml (p<001).
Plasma somatostatin returned to basal concentrations by 40 minutes and gradually declined below basal concentrations thereafter. Plasma gastrin, gastric inhibitory polypeptide and pancreatic polypeptide concentrations did not change during this infusion. Plasma motilin fell moderately during the acid infusion although this reduction reached significance at one time point only; basal 317±59 pg/ml, 247+57 pg/ml at 20 minutes (p<0.05). Plasma motilin returned to preinfusion levels by 60 minutes after which it declined below basal concentrations.
Discussion
The present study was designed to investigate the potential role of gastric acid as a factor mediating the release of circulating somatostatin in man. Intragastric and intraduodenal infusion of HC1 in dogs raises portal and peripheral plasma somatostatin and intraluminal somatostatin concentrations.15 1617 Somatostatin released into the local draining veins after intragastric instillation of a protein meal in dogs is enhanced by prior adjustment of the meal to a pH of 2.18 In the present study plasma somatostatin concentrations were not significantly altered by either an intragastric infusion of 15 mmol 0-1 N HC1 given over 30 minutes, a dose which mimics the estimated maximal postprandial gastric acid output19 or intraduodenal infusion of 4 mmol 0-1 N HC1 over five minutes, a stimulus reported to raise plasma concen- trations of other putative gut hormones.20 21 22 23 During an intraduodenal infusion of 60 mmol 0O1 N HC1 over 30 minutes, a grossly supraphysiological dose which caused a sustained reduction in intraduodenal pH not found distal to the duodenal bulb in healthy subjects,24 25 there was a moderate rise in plasma somatostatin concentrations from 32±3 pg/ ml to a peak of 54±11 pg/ml. This response should be compared with the effect of a 30 minute infusion into the second part of the duodenum of 100 calories of fat emulsion in normal subjects in which plasma somatostatin rose from a basal concentration of 30±3 pg/ml to a peak of 101±11 pg/ml.26 Thus we conclude that even grossly unphysiological duodenal acidification is a submaximal stimulus of plasma somatostatin. The failure to reproduce in man the effects on plasma somatostatin of intragastric and intraduodenal acidification found in dogs may be because of species variation and differences in assay technique. Furthermore, the increases in plasma somatostatin in dogs were most marked in local draining veins. Our studies are confined to the systemic circulation. 
